Journal of Traditional Chinese Medicine ›› 2017, Vol. 37 ›› Issue (01): 88-95.

Previous Articles     Next Articles

Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H_22 hepatocellular carcinoma

Zhao Xinyue, Xi Shengyan, Wang Yanhui, Xu Yangxinzi, Pollock Galia, Su Yu, Cheng Yao, Loy Guanjie, Liu Pei   

  1. Department of Traditional Chinese Medicine, Medical College of Xiamen University; Cancer Research Center of Xiamen University;Department of Internal Medicine, John Buhler Research Centre, University of Manitoba;
  • Accepted:2017-02-15 Online:2017-02-15 Published:2022-04-04
  • Supported by:
    the National Natural Science Foundation of China(From Regulating Pathological Angiogenesis and the Hepatic Fibrosis Way to Compare the Effects and Mechanisms between Taohongsiwu Decoction and its Absorbed Bioactive Compound,No.81202659), the Xiamen Science and Technology Key Program Plan Grant(Prevention and Treatment Mechanism Study of Traditional Chinese Medicine on Common Digestive Tract Cancer of Fujian and Taiwan,No.3502Z20100006), the Xiamen Science and Technology Program Plan Grant(the Development and Application and Basic Research of Ciji Hua'ai Baosheng Soluble Granules,No.3502Z20153027), the Natural Science Foundation of Fujian(China)(Negative Effect of Safflower Ingredient and Taohong formula on Mechanism of Pathological Angiogenesis and PI3K-Akt Signaling,No.2014J01373), the Scientific Research Start Foundation for New Teacher of Xiamen University(Correlated Mechanism Study of Safflower Ingredient Regulating Digestive Tract Tumor,No.ZK1014)

Abstract: OBJECTIVE: To investigate the efficacy of Ciji Hua'ai Baosheng formula(CHBF) on microvessel density(MVD) and vascular endothelial growth factor(VEGF), kinase insert domain-containing receptor(KDR) and basic fibroblast growth factor(b FGF) expression in serum and tumor tissue of mice receiving chemotherapy for the treatment of H22 hepatocellular carcinoma.METHODS: Sixty Kunming mice were injected subcutaneously with H22 hepatoma carcinoma cell suspensions into the right anterior armpit. Seven days later, all transplanted tumor were formed and the mice were intraperitoneally injected 200 mg/kg cytoxan(CTX) to establish the models of tumor-bearing mouse chemotherapy, then they were randomly divided into model group, continuing CTX chemotherapy group(CTX group), and three CHBF(117, 58.5 and 29.25 g/kg) groups. After ten days of treatments, histology was observed, contents of VEGF, KDR and b FGF in serum and tumor tissue were measured by enzyme-linked immunosorbent assay(ELISA), VEGF and b FGF protein expression and MVD tagged by CD34 were detected by immunohistochemisty.RESULTS: MVD in CHBF(117, 58.5 g/kg) and CTX groups was significantly lower than that in model group(P < 0.01); expressions of VEGF, KDR and b FGF in serum and tumor tissue in CHBF(117 g/kg)group were less than those in model group(P < 0.01); the expressions of MVD, VEGF and b FGF in tumor tissue of CHBF(117 g/kg) groupwere also less than those in CTX group(P < 0.05;P < 0.01).CONCLUSION: CHBF can effectively reduce the expression of VEGF, KDR and b FGF in serum and tumor tissue, and decrease MVD and delay tumor progression.

Key words: Drug therapy, Angiogenesis inhibitors, Vascular endothelial growth factors, Receptors, vascular endothelial growth factor, Basic fibroblast growth factor 2, Ciji Hua'ai Baosheng formula

Cite this article

Zhao Xinyue, Xi Shengyan, Wang Yanhui, Xu Yangxinzi, Pollock Galia, Su Yu, Cheng Yao, Loy Guanjie, Liu Pei. Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H_22 hepatocellular carcinoma[J]. Journal of Traditional Chinese Medicine, 2017, 37(01): 88-95.